# Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

NDC: 58118-8005
Generic name: Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
Labeler / Manufacturer: Clinical Solutions Wholesale, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20171213

FDA application: ANDA207000

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 2 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58118-8005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58118-8005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=273b79ac-2c62-4407-9cd1-2a2964ef13ba